What Johnson & Johnson (JNJ) investors may be watching now Johnson & Johnson (JNJ) shares have recently drawn attention after ...

In the nearly nine months spanning from May 2025 to February 2026, Johnson & Johnson (JNJ)’s stock experienced a remarkable 52% increase, driven ...

We recently published 10 Stocks on Jim Cramer’s Radar. Johnson & Johnson (NYSE:JNJ) is one of the stocks that on Jim Cramer’s ...

Johnson & Johnson's (NYSE: JNJ) stock price is up more than 7% since the first trading day of November. What's going on with this healthcare giant? Well, J&J posted strong third-quarter results in mid ...

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does ...

Last month, Johnson & Johnson surged following a well-received quarterly earnings release. Despite a sluggish start to November, a spate of positive news has since sent the healthcare stock's shares ...

Johnson & Johnson (JNJ) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

The average one-year price target for Johnson & Johnson (XTRA:JNJ) has been revised to 175,39 € / share. This is an increase of 11.93% from the prior estimate of 156,70 € dated September 29, 2025. The ...

If you have been wondering whether Johnson & Johnson is fairly priced or offering value right now, this article will walk ...

The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and ...

J&J beat Wall Street estimates on sales and profits in the third quarter. The company recently announced the acquisition of a biotech with an innovative cancer treatment. 10 stocks we like better than ...